{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T14:10:06Z","timestamp":1764252606317,"version":"3.46.0"},"reference-count":158,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2025,10,3]]},"DOI":"10.1080\/17512433.2025.2573783","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:21:57Z","timestamp":1760037717000},"page":"797-813","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6627-2146","authenticated-orcid":false,"given":"Mayalen","family":"Uthurriague","sequence":"first","affiliation":[{"name":"CHU de Bordeaux","place":["Bordeaux, France"]},{"name":"University of Bordeaux","place":["Bordeaux, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-7399","authenticated-orcid":false,"given":"Estibaliz","family":"Lazaro","sequence":"additional","affiliation":[{"name":"University of Bordeaux","place":["Bordeaux, France"]},{"name":"CHU Bordeaux","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3029-8739","authenticated-orcid":false,"given":"Christophe","family":"Richez","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux","place":["Bordeaux, France"]},{"name":"University of Bordeaux","place":["Bordeaux, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-3639","authenticated-orcid":false,"given":"Patrick","family":"Blanco","sequence":"additional","affiliation":[{"name":"University of Bordeaux","place":["Bordeaux, France"]},{"name":"CHU Bordeaux","place":["Bordeaux, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-616X","authenticated-orcid":false,"given":"No\u00e9mie","family":"Gensous","sequence":"additional","affiliation":[{"name":"University of Bordeaux","place":["Bordeaux, France"]},{"name":"CHU Bordeaux","place":["Bordeaux, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.12.008"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211663"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2024.07.006"},{"issue":"4","key":"e_1_3_5_6_1","first-page":"383","article-title":"Systemic lupus erythematosus: diagnosis and treatment","volume":"107","author":"Lam N-C","year":"2023","unstructured":"Lam N-C, Brown JA, Sharma R. Systemic lupus erythematosus: diagnosis and treatment. Am Fam Physician. 2023;107(4):383\u2013395.","journal-title":"Am Fam Physician"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.banm.2021.10.006"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.39"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.03.022"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874312901307010087"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.09.009"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224609"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.10.004"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224762"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2268284"},{"issue":"1","key":"e_1_3_5_16_1","first-page":"159124","article-title":"Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications","volume":"2013","author":"Marchetti T","year":"2013","unstructured":"Marchetti T, Cohen M, de Moerloose P. Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications. J Immunol Res. 2013;2013(1):159124.","journal-title":"J Immunol Res"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0291"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.7.481"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-2139-9"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2017.66685"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2017.05.006"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2019.09.002"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2235"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2019-0034"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.08.005"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30069-4"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60709-X"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2015-000131"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105316"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1269168"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.09.007"},{"key":"e_1_3_5_32_1","unstructured":"Actualit\u00e9 - Les enfants expos\u00e9s \u00e0 l\u2019hydroxychloroquine pendant la grossesse de leur m\u00e8re courent un risque plus \u00e9lev\u00e9 de malformation grave \u00e0 la naissance [Internet]. ANSM; [cited 2025 Jul 21]. Available from: https:\/\/ansm.sante.fr\/actualites\/les-enfants-exposes-a-lhydroxychloroquine-pendant-la-grossesse-de-leur-mere-courent-un-risque-plus-eleve-de-malformation-grave-a-la-naissance"},{"key":"e_1_3_5_33_1","unstructured":"[cited 2025 Jul 21]. Available from: https:\/\/www.hma.eu\/fileadmin\/dateien\/Human_Medicines\/CMD_h_\/CMDh_pressreleases\/2023\/CMDh_press_release_-_February_2023.pdf"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2024.105713"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.722511"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa592"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae168"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1191\/096120301678646137"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.03.006"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2020.1868652"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212535"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2024-eular.3981"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211007199"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06496-2"},{"issue":"25","key":"e_1_3_5_45_1","first-page":"00076","article-title":"Exposure to hydroxychloroquine in early pregnancy and incidence of pre-eclampsia and pre-term delivery in patients with systemic lupus erythematosus in Sweden: a nationwide population-based cohort study","volume":"2665","author":"Nguyen NV","year":"2025","unstructured":"Nguyen NV, Sandstr\u00f6m A, Svenungsson E, et al. Exposure to hydroxychloroquine in early pregnancy and incidence of pre-eclampsia and pre-term delivery in patients with systemic lupus erythematosus in Sweden: a nationwide population-based cohort study. Lancet Rheumatol. 2025;S2665-9913(25):00076\u20131.","journal-title":"Lancet Rheumatol"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41191"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209770"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208840"},{"issue":"25","key":"e_1_3_5_49_1","first-page":"00132","article-title":"Hydroxychloroquine use in pregnant women with systemic lupus erythematosus: the pill that shields","volume":"2665","author":"de Fr\u00e9mont G M","year":"2025","unstructured":"de Fr\u00e9mont G M, Guettrot-Imbert G, Costedoat-Chalumeau N. Hydroxychloroquine use in pregnant women with systemic lupus erythematosus: the pill that shields. Lancet Rheumatol. 2025;S2665-9913(25):00132\u20138.","journal-title":"Lancet Rheumatol"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.02.023"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319863111"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020485"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.089268"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.045"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2024-327570"},{"key":"e_1_3_5_56_1","unstructured":"CRAT L. Hydroxychloroquine \u2013 Allaitement \u2013 Le CRAT [Internet]. 2021 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/3389\/"},{"key":"e_1_3_5_57_1","unstructured":"Crat L. Cortico\u00efdes \u2013 Grossesse \u2013 Le CRAT [Internet]. 2021 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/5009\/"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X19847832"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000559094.16348.f1"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.08.063"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.02.015"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.06.012"},{"key":"e_1_3_5_63_1","doi-asserted-by":"crossref","unstructured":"Walters A McKinlay C Middleton P et al. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes - walters A - 2022 | cochrane library. [cited 2025 Sep 26].","DOI":"10.1002\/14651858.CD003935.pub5"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.109908.1"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.04.013"},{"key":"e_1_3_5_66_1","unstructured":"CRAT L. Cortico\u00efdes \u2013 Allaitement \u2013 Le CRAT [Internet]. 2021 [cited 2025 Apr 12]. Available from: https:\/\/www.lecrat.fr\/5011\/"},{"key":"e_1_3_5_67_1","unstructured":"CRAT L. Azathioprine \u2013 Grossesse \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8894\/"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102525"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2017.06.006"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx123"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac372"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2021.102083"},{"key":"e_1_3_5_73_1","unstructured":"CRAT L. Azathioprine \u2013 Allaitement \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8893\/"},{"key":"e_1_3_5_74_1","unstructured":"CRAT L. M\u00e9thotrexate \u2013 Grossesse \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/3331\/"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38368"},{"key":"e_1_3_5_76_1","unstructured":"METHOTREXATE label [Internet]. [cited 2025 Sep 26]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/040054s015 s016 s017.pdf"},{"key":"e_1_3_5_77_1","unstructured":"CRAT L. M\u00e9thotrexate \u2013 Allaitement \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/3333\/"},{"key":"e_1_3_5_78_1","unstructured":"Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis? [cited 2025 Apr 12]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15683089\/"},{"key":"e_1_3_5_79_1","unstructured":"CRAT L. Cyclophosphamide \u2013 Grossesse \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8912\/"},{"key":"e_1_3_5_80_1","unstructured":"CRAT L. Cyclophosphamide \u2013 Allaitement \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8911\/"},{"key":"e_1_3_5_81_1","unstructured":"CRAT L. Mycoph\u00e9nolate \u2013 Grossesse \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8864\/"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1542\/neo.11-10-e578"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.3.219"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14085"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1556743"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000252683.74584.29"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.35223"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12238"},{"key":"e_1_3_5_89_1","unstructured":"CRAT L. Mycoph\u00e9nolate \u2013 Allaitement \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8863\/"},{"key":"e_1_3_5_90_1","unstructured":"CRAT L. Tacrolimus \u2013 Grossesse \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8924\/"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000769"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15414"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0034-x"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.09.002"},{"key":"e_1_3_5_95_1","unstructured":"CRAT L. Ciclosporine \u2013 Grossesse \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8945\/"},{"key":"e_1_3_5_96_1","unstructured":"Cerba Y. Grossesse apr\u00e8s transplantation r\u00e9nale : retour d\u2019exp\u00e9rience du CHU Grenoble Alpes."},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12494"},{"key":"e_1_3_5_98_1","unstructured":"213716s000lbl.pdf [Internet]. [cited 2025 Apr 11]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/213716s000lbl.pdf"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2023.12.039"},{"key":"e_1_3_5_100_1","unstructured":"Voclosporin (Lupkynis) Use During Pregnancy [Internet]. Drugs.com. [cited 2025 Apr 11]. Available from: https:\/\/www.drugs.com\/pregnancy\/voclosporin.html"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S282604"},{"key":"e_1_3_5_102_1","unstructured":"Shah VR Bankole AV. Statpearls [internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Apr 11]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK592419\/"},{"key":"e_1_3_5_103_1","unstructured":"CRAT L. Ciclosporine \u2013 Allaitement \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8946\/"},{"key":"e_1_3_5_104_1","unstructured":"CRAT L. Tacrolimus \u2013 Allaitement \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/8925\/"},{"key":"e_1_3_5_105_1","unstructured":"lupkynis-epar-product-information_en.pdf [Internet]. [cited 2025 Apr 11]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/lupkynis-epar-product-information_en.pdf"},{"key":"e_1_3_5_106_1","unstructured":"MabThera. INN-rituximab [Internet]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mabthera-epar-product-information_en.pdf"},{"key":"e_1_3_5_107_1","unstructured":"CRAT L. Rituximab \u2013 Grossesse \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/10810\/"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000734"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-295444"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000453"},{"key":"e_1_3_5_111_1","unstructured":"CRAT L. Rituximab \u2013 Allaitement \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/10811\/"},{"key":"e_1_3_5_112_1","unstructured":"label [Internet]. [cited 2025 Sep 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/125370s085lbl.pdf"},{"key":"e_1_3_5_113_1","unstructured":"CRAT L. B\u00e9limumab- Grossesse \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/17653\/"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdr2.2091"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222505"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.03.005"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.05.006"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221143286"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221141805"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.06.005"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213004"},{"key":"e_1_3_5_122_1","unstructured":"saphnelo-epar-product-information_en.pdf [Internet]. [cited 2025 Apr 11]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/saphnelo-epar-product-information_en.pdf"},{"key":"e_1_3_5_123_1","unstructured":"761123s000lbl.pdf [Internet]. [cited 2025 Apr 11]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/761123s000lbl.pdf"},{"key":"e_1_3_5_124_1","unstructured":"Anifrolumab (Saphnelo) Use During Pregnancy [Internet]. Drugs.com. [cited 2025 Apr 11]. Available from: https:\/\/www.drugs.com\/pregnancy\/anifrolumab.html"},{"key":"e_1_3_5_125_1","unstructured":"Anifrolumab. Drugs and Lactation Database (LactMed\u00ae). Internet. Bethesda (MD): National Institute of Child Health and Human Development; 2006 [cited 2025 Apr 11]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK573042\/"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221086719"},{"key":"e_1_3_5_127_1","unstructured":"CRAT L. Anticoagulants\/Anti-agr\u00e9gants plaquettaires \u2013 Grossesse \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/9423\/"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214434"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2018.08.001"},{"issue":"2","key":"e_1_3_5_130_1","first-page":"41","article-title":"Antiphospholipid syndrome during pregnancy: the state of the art","volume":"5","author":"Di Prima FAF","year":"2011","unstructured":"Di Prima FAF, Valenti O, Hyseni E, et al. Antiphospholipid syndrome during pregnancy: the state of the art. J Prenat Med. 2011;5(2):41\u201353.","journal-title":"J Prenat Med"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-017-0575-x"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2024-105766"},{"key":"e_1_3_5_133_1","unstructured":"CRAT L. Anticoagulants\/Anti-agr\u00e9gants plaquettaires \u2013 Allaitement \u2013 Le CRAT [Internet]. 2024 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/9422\/"},{"key":"e_1_3_5_134_1","unstructured":"CRAT L. Ramipril \u2013 Grossesse \u2013 Le CRAT [Internet]. 2022 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/7328\/"},{"key":"e_1_3_5_135_1","unstructured":"CRAT L. Ramipril \u2013 Allaitement \u2013 Le CRAT [Internet]. 2022 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/7329\/"},{"key":"e_1_3_5_136_1","unstructured":"CRAT L. Acide valpro\u00efque \u2013 Grossesse \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 12]. Available from: https:\/\/www.lecrat.fr\/12594\/"},{"key":"e_1_3_5_137_1","unstructured":"CRAT L. Carbamaz\u00e9pine \u2013 Grossesse \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 12]. Available from: https:\/\/www.lecrat.fr\/12249\/"},{"key":"e_1_3_5_138_1","unstructured":"CRAT L. Acide valpro\u00efque \u2013 Allaitement \u2013 Le CRAT [Internet]. 2022 [cited 2025 Apr 12]. Available from: https:\/\/www.lecrat.fr\/12595\/"},{"key":"e_1_3_5_139_1","unstructured":"CRAT L. Carbamaz\u00e9pine \u2013 Allaitement \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 12]. Available from: https:\/\/www.lecrat.fr\/12477\/"},{"key":"e_1_3_5_140_1","unstructured":"CRAT L. K\u00e9toprof\u00e8ne \u2013 Grossesse \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/15338\/"},{"key":"e_1_3_5_141_1","unstructured":"CRAT L. K\u00e9toprof\u00e8ne \u2013 Allaitement \u2013 Le CRAT [Internet]. 2023 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/15343\/"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-222006"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2016.01.005"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001035"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reumae.2024.10.003"},{"key":"e_1_3_5_146_1","unstructured":"CRAT L. Vaccins \u2013 Grossesse \u2013 Le CRAT [Internet]. 2022 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/6584\/"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58101371"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S87828"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103292"},{"key":"e_1_3_5_150_1","unstructured":"CRAT L. Vaccins \u2013 Allaitement \u2013 Le CRAT [Internet]. 2022 [cited 2025 Apr 11]. Available from: https:\/\/www.lecrat.fr\/6585\/"},{"issue":"25","key":"e_1_3_5_151_1","first-page":"00741","article-title":"Women\u2019s knowledge concerning the impact of chronic systemic diseases and related treatments on pregnancy","volume":"0248","author":"Rolland M","year":"2025","unstructured":"Rolland M, Souchaud-Debouverie O, Bodard Q. Women\u2019s knowledge concerning the impact of chronic systemic diseases and related treatments on pregnancy. Rev Med Interne. 2025;S0248-8663(25):00741\u20136.","journal-title":"Rev Med Interne"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.09.021"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17093"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa064"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218356"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(25)00129-8"},{"issue":"3","key":"e_1_3_5_157_1","first-page":"159","article-title":"Prospective assessment of a multidisciplinary meeting dedicated to inflammatory and vascular diseases during pregnancy","volume":"49","author":"Blondeel J","year":"2021","unstructured":"Blondeel J, Mattuizzi A, Delmas Y, et al. Prospective assessment of a multidisciplinary meeting dedicated to inflammatory and vascular diseases during pregnancy. Gynecol Obstet Fertil Senol. 2021;49(3):159\u2013165.","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3131-7"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf334"},{"key":"e_1_3_5_160_1","unstructured":"Lupus A guide to Pregnancy [Internet]. Available from: https:\/\/lupusuk.org.uk\/wp-content\/uploads\/2024\/08\/LUPUS-A-Guide-to-Pregnancy-V1.pdf"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2025.2573783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T14:08:03Z","timestamp":1764252483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2025.2573783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":158,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"alternative-id":["10.1080\/17512433.2025.2573783"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2025.2573783","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"type":"print","value":"1751-2433"},{"type":"electronic","value":"1751-2441"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}